Cost-Effectiveness of Shortening Treatment Duration Based on Interim PET Outcome in Patients With Diffuse Large B-cell Lymphoma-Reference-Cited by-同舟云学术

Cost-Effectiveness of Shortening Treatment Duration Based on Interim PET Outcome in Patients With Diffuse Large B-cell Lymphoma

Published:2021-11 Issue: Volume: Page:
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Greuter MJE^ORCID,Eertink JJ,Jongeneel G,Dührsen U,Hüttmann A,Schmitz C,Lugtenburg PJ,Barrington SF,Mikhaeel NG,Ceriani L,Zucca E,Carr R,Györke T,Burggraaff CN,de Vet HCW,Hoekstra OS,Zijlstra JM,Coupé VMH

Funder

Dutch Cancer Society

Stiftung Deutsche Krebshilfe

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference37 articles.

1. Non-Hodgkin lymphoma;Armitage;The Lancet,2017

2. Lymfoom. Accessed from: https://hovon.nl/nl/behandelrichtlijnen/lymfoom. Accessed at: January 22, 2021.

3. Obinutuzumab or rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in previously untreated diffuse large B-Cell lymphoma;Vitolo;J. Clin. Oncol.,2017

4. FDG-PET as a biomarker for early response in diffuse large B-cell lymphoma as well as in Hodgkin lymphoma? Ready for implementation in clinical practice?;Zijlstra;Haematologica,2016

5. Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60);Pfreundschuh;Lancet Oncol,2008

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness of one-stop-shop [18F]Fluorocholine PET/CT to localise parathyroid adenomas in patients suffering from primary hyperparathyroidism;European Journal of Nuclear Medicine and Molecular Imaging;2024-06-05